Literature DB >> 12705707

Hospital experience and outcomes for esophageal variceal bleeding.

Sydney Morss Dy1, David M Cromwell, Paul J Thuluvath, Eric B Bass.   

Abstract

OBJECTIVE: Although higher hospital volume has been associated with better outcomes for many surgical procedures, this relationship does not appear to hold for most common medical diagnoses. We evaluated whether there is a volume-outcome relationship for a rarer and higher-mortality medical diagnosis, esophageal variceal bleeding.
DESIGN: Cross-sectional retrospective study of hospital discharge data.
SETTING: All Maryland hospitals from 1992 through 1996. STUDY PARTICIPANTS: All patients with diagnosis codes for both esophageal variceal bleeding and cirrhosis in relevant diagnosis-related groups. MAIN OUTCOME MEASURE: Mortality for esophageal variceal bleeding. We classified hospitals by tertiles of admissions as high (> 17 cases of variceal bleeding per year), medium (12-17 cases per year) or low (< 12 cases per year) volume.
RESULTS: There were seven high-volume, 13 medium-volume, and 29 low-volume hospitals. Overall in-hospital mortality was 15%. After multiple regression was used to adjust for differences in age, sex, ethnicity, emergency room admission, use of procedures, complexity, Medicaid status, transfer status, and clinical variables associated with mortality from variceal bleeding, there were no significant differences between the high-, medium-, and low-volume hospital groups in in-hospital mortality (16%, 15%, and 13%, respectively). There were also no significant differences in hospital charges (dollar 17 000, dollar 15 000, and dollar 14 000, respectively) or length of stay (8.5, 8.7, and 7.8 days, respectively) between hospital volume groups.
CONCLUSIONS: The volume-outcome relationship may not pertain to some medical diseases such as esophageal variceal bleeding. Alternatively, the biases inherent in research using administrative data may make this relationship appear weaker for some medical than for surgical diagnoses in this type of study.

Entities:  

Mesh:

Year:  2003        PMID: 12705707     DOI: 10.1093/intqhc/mzg016

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  7 in total

1.  Volume of hospital is important for the prognosis of high-risk patients with nonvariceal upper gastrointestinal bleeding (NVUGIB).

Authors:  Jin Woo Choi; Seong Woo Jeon; Jung Gu Kwon; Dong Wook Lee; Chang Yoon Ha; Kwang Bum Cho; Byung Ik Jang; Jung Bae Park; Youn Sun Park
Journal:  Surg Endosc       Date:  2016-12-07       Impact factor: 4.584

2.  General aspects of the treatment of alcoholic hepatitis.

Authors:  Michael J Babineaux; Bhupinderjit S Anand
Journal:  World J Hepatol       Date:  2011-05-27

3.  The effect of weekend versus weekday admission on outcomes of esophageal variceal hemorrhage.

Authors:  R P Myers; G G Kaplan; A M Shaheen
Journal:  Can J Gastroenterol       Date:  2009-07       Impact factor: 3.522

4.  Efficacy and Safety of Ligation Combined With Sclerotherapy for Patients With Acute Esophageal Variceal Bleeding in Cirrhosis: A Meta-Analysis.

Authors:  Juan Su; Huilin Zhang; Maifang Ren; Yanan Xing; Yuefei Yin; Lihua Liu
Journal:  Front Surg       Date:  2021-06-09

5.  Evaluating compulsory minimum volume standards in Germany: how many hospitals were compliant in 2004?

Authors:  Werner de Cruppé; Christian Ohmann; Karl Blum; Max Geraedts
Journal:  BMC Health Serv Res       Date:  2007-10-17       Impact factor: 2.655

6.  Esophageal capsule endoscopy is not the optimal technique to determine the need for primary prophylaxis in patients with cirrhosis.

Authors:  Karen L Krok; Rebecca Rankin Wagennar; Sergey V Kantsevoy; Paul J Thuluvath
Journal:  Arch Med Sci       Date:  2016-04-12       Impact factor: 3.318

7.  Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study.

Authors:  Chueh-Ling Liu; Cheng-Kun Wu; Hon-Yi Shi; Wei-Chen Tai; Chih-Ming Liang; Shih-Cheng Yang; Keng-Liang Wu; Yi-Chun Chiu; Seng-Kee Chuah
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.